View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Novartis AG: 1 director

A director at Novartis AG sold 2,500 shares at 98.528CHF and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

Dominic Rose ... (+2)
  • Dominic Rose
  • Naresh Chouhan

Novartis AG: Avidity acquisition builds rare disease pipeline despite ...

The acquisition temporarily raises Novartis’ adjusted leverage, while significantly strengthening the pipeline and supporting mid to long-term growth.

Martial Descoutures
  • Martial Descoutures
Martial Descoutures
  • Martial Descoutures

Australian Clinical Labs Limited: 1 director

A director at Australian Clinical Labs Limited maiden bought 70,000 shares at 2.770AUD and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over t...

Martial Descoutures
  • Martial Descoutures
Martial Descoutures
  • Martial Descoutures
Dominic Rose ... (+2)
  • Dominic Rose
  • Naresh Chouhan
Martial Descoutures
  • Martial Descoutures
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch